Trial intelligence / Profile preview

Lisinopril Dose Titration in Pediatric Hypertension

NCT02184858Phase 4Completed

Sponsor
Ghent University
Start
Jun 2014
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lisinopril in hypertension (HTN), sponsored by Ghent University. Started Jun 2014; status: completed.

02

Drugs

lisinopril
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02184858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02184858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call